Showing all 16 results
Mounjaro 10mg Injection contains tirzepatide 10mg, a once-weekly injectable medicine that activates both GIP and GLP-1 receptors. It is used under medical supervision to improve blood glucose control in adults with type 2 diabetes and can also reduce appetite and food intake, supporting weight reduction.
Mounjaro 15mg Injection contains tirzepatide 15mg, a once-weekly injectable medicine that activates both GIP and GLP-1 receptors. It is used under medical supervision to improve blood glucose control in adults with type 2 diabetes and can also reduce appetite and food intake, supporting weight reduction.
Mounjaro 2.5mg Injection contains tirzepatide 2.5mg, a once-weekly injectable medicine that activates GIP and GLP-1 receptors. It is used under medical supervision to improve blood glucose control in adults with type 2 diabetes and may also reduce appetite and food intake.
Mounjaro 5mg Injection contains tirzepatide 5mg, a once-weekly injectable medicine that activates both GIP and GLP-1 receptors. It is used under medical supervision to improve blood glucose control in adults with type 2 diabetes and can also reduce appetite and food intake, potentially supporting weight reduction.
Mounjaro 7.5mg Injection contains tirzepatide 7.5mg, a once-weekly injectable medicine that activates both GIP and GLP-1 receptors. It is used under medical supervision to improve blood glucose control in adults with type 2 diabetes and can also reduce appetite and food intake, supporting weight reduction.
Product Name: RYBELSUS 14MG
Active Ingredient: Semaglutide 14mg
Dosage Form: Tablet
Drug Class: GLP-1 receptor agonist
Prescription Status: Prescription medicine
RYBELSUS 14MG contains Semaglutide 14mg, an oral GLP-1 receptor agonist used for type 2 diabetes. It helps regulate blood glucose by increasing glucose-dependent insulin secretion, reducing glucagon secretion and slowing gastric emptying. Reduced appetite and weight loss may also occur in some patients.
Product Name: RYBELSUS 3MG
Active Ingredient: Semaglutide 3mg
Dosage Form: Tablet
Drug Class: GLP-1 receptor agonist
Product Category: Semaglutide / Diabetes Medication
Prescription Status: Prescription medicine
RYBELSUS 3MG contains Semaglutide 3mg, an oral GLP-1 receptor agonist. Semaglutide can reduce appetite and food intake and may result in weight loss in some patients. RYBELSUS 3mg is primarily used for type 2 diabetes and the 3mg strength is generally used as the initial dose rather than a maintenance dose.
Product Name: RYBELSUS 7MG
Active Ingredient: Semaglutide 7mg
Dosage Form: Tablet
Drug Class: GLP-1 receptor agonist
Prescription Status: Prescription medicine
RYBELSUS 7MG contains Semaglutide 7mg, an oral GLP-1 receptor agonist used to improve blood glucose control in adults with type 2 diabetes, alongside diet and exercise. Semaglutide may also reduce appetite and food intake, which can result in weight loss in some patients.
SEMALIX 14MG contains Semaglutide 14mg, an oral GLP-1 receptor agonist used to improve blood-glucose control in adults with type 2 diabetes. Semaglutide may also reduce appetite and food intake, and decreased body weight can occur during treatment. The 14mg strength is a recommended maintenance dose following dose escalation.
SEMALIX 3MG contains Semaglutide 3mg, an oral GLP-1 receptor agonist used to improve blood glucose control in adults with type 2 diabetes. Semaglutide may also reduce appetite and food intake, which can contribute to weight loss in some patients. The 3mg strength is generally used as the initial dose before dose escalation.
SEMALIX 7MG contains Semaglutide 7mg, an oral GLP-1 receptor agonist used to improve blood-glucose control in adults with type 2 diabetes. Semaglutide may reduce appetite and food intake, and some patients may experience weight loss during treatment.
WEGOVY 0.25MG INJECTION contains Semaglutide 0.25mg, a GLP-1 receptor agonist used for chronic weight management in eligible adults and adolescents. It is used alongside a reduced-calorie diet and increased physical activity. The 0.25mg strength is the starting dose and is administered once weekly.
WEGOVY 0.5MG INJECTION contains Semaglutide 0.5mg, a GLP-1 receptor agonist used for chronic weight management in eligible patients, together with a reduced-calorie diet and increased physical activity. The 0.5mg strength is part of the dose-escalation schedule and is administered once weekly.
Wegovy 1.7mg Injection contains semaglutide 1.7mg, a GLP-1 receptor agonist used for chronic weight management in eligible patients. It works by helping regulate appetite, increase feelings of fullness, and reduce food intake when used together with a reduced-calorie diet and increased physical activity.
Wegovy 1mg Injection contains semaglutide 1mg, a GLP-1 receptor agonist used as part of a comprehensive weight-management program in eligible adults and certain adolescents. It helps reduce appetite and food intake and is used alongside a reduced-calorie diet and increased physical activity.
Wegovy 2.4mg Injection contains semaglutide 2.4mg, a GLP-1 receptor agonist used for chronic weight management in eligible patients. It helps reduce hunger and food intake and increase feelings of fullness when used together with a reduced-calorie diet and increased physical activity.
End of content
End of content
Be the first to know about our new arrivals, exclusive offers and the latest fashion update.
By subscribing, you agree to our privacy policy.
We have something special for you
Use above code to get 20% off for your first order when checkout. Don't miss it.
In order to provide you a personalized shopping experience, our site uses cookies. By continuing to use this site, you are agreeing to our cookie policy.
Don't have an account yet? Sign up
No items in your cart. Go on, fill it up with something you love!
Start Shopping Now
Select your preferred currency for shopping on our website.
Prices will be displayed in your selected currency.
